ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ)
$2.08 -0.01 (-0.4785%)
Analysed ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) News Sources
Alterity Therapeutics Achieves Alignment with U.S. FDA on Pivotal Phase 3 Program for ATH434 in Multiple System Atrophy
09-06-2026
yahoo.com
Alterity Therapeutics Receives FDA End-of-Phase 2 Meeting Minutes Confirming Registrational Pathway for ATH434 in Multiple System Atrophy
07-07-2026
yahoo.com
Alterity Therapeutics Releases Appendix 4C – Q4 FY26 Quarterly Cash Flow Report & Corporate Update
30-07-2026
yahoo.com
Alterity Therapeutics to Present at the 46th Annual Canaccord Genuity Growth Conference
06-08-2026
yahoo.com
Ather Energy (NSEI:ATHERENERG) Stock Sees Modest Fair Value Lift On Stronger Growth Assumptions
09-10-2026
yahoo.com
Alterity Therapeutics Announces Granting of New U.S. Composition of Matter Patent for ATH434
12-08-2026
yahoo.com
Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026
03-09-2026
yahoo.com
Alterity Therapeutics CEO speaks with Proactive at the ASX SMIDcaps Conference
23-09-2026
yahoo.com
Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data in Multiple System Atrophy at the 2026 International Congress of Parkinson’s Disease and Movement Disorders
05-10-2026
yahoo.com
Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference
09-10-2026
yahoo.com
What is the current price of ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ)?
The current price of ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) is $2.08.
ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) absolute price change since previous trading day?
The absolute price change of ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) since the previous trading day is $-0.01.
ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) percentage price change since previous trading day?
The percentage price change of ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) since the previous trading day is -0.4785%.
What is the most recent average sentiment score for ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ)?
The most recent average sentiment score for ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ)?
The most recent sentiment for ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ) is .
SEC-8K** Filing Available For ALTERITY THERAPEUTICS-ADR (ATHE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.